Works matching IS 17588340 AND DT 2017 AND VI 9 AND IP 12
Results: 7
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 12, p. 731, doi. 10.1177/1758834017742627
- By:
- Publication type:
- Article
FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 12, p. 797, doi. 10.1177/1758834017742576
- By:
- Publication type:
- Article
Myxofibrosarcoma primary cultures: molecular and pharmacological profile.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 12, p. 755, doi. 10.1177/1758834017737472
- By:
- Publication type:
- Article
Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy, safety and place in therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 12, p. 769, doi. 10.1177/1758834017741074
- By:
- Publication type:
- Article
Somatostatin analogs: is one better than other?
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 12, p. 817, doi. 10.1177/1758834017741073
- By:
- Publication type:
- Article
DNM3, p65 and p53 from exosomes represent potential clinical diagnosis markers for glioblastoma multiforme.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 12, p. 741, doi. 10.1177/1758834017737471
- By:
- Publication type:
- Article
Targeted therapy of brain metastases: latest evidence and clinical implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 12, p. 781, doi. 10.1177/1758834017736252
- By:
- Publication type:
- Article